MedPage Today on MSN
Blood Test May Be a 'Viable Alternative' in Liver Cancer Surveillance
This multi-target blood test "offers the potential for improved patient outcomes through earlier HCC detection," John said ...
A new article outlines a new tool that measures blood inflammation as a marker for poor CAR T therapy outcomes. Researchers with City of Hope, one of the largest and most advanced cancer research and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback